IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Home Page: www.sandoz.com.tr
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 160-170 mil lion
Prod ucts (% of Sales by Lead ing 5): 50-55%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
PANTO (antiulcerant)
LANSAZOL (antiulcerant)
AMOKSILAV (pen i cil lin broad spec trum)
VERMIDON (an al ge sic non-nar cotic)
GLUKOFEN (antidiabetic oral)
Ther a peu tic Range:
ant ac ids/antiflatulents/antiulcerants 40%
antibacterials sys temic 14%
an al ge sics 13%
cough and cold prep a ra tions 8%
drugs used in di a be tes 6%
Lead ing Dose Forms:
coated tab lets 48%
liq uids 16%
cap sules 16%
tab lets 15%
am poules 2%
UK
CIBA VI SION
Full Name: CV Man u fac tur ing and Sup ply (UK)
Lim ited
Street Ad dress: Guild ford Road Trad ing Es tate,
Farn ham, Sur rey GU9 9PZ
Tel: +44 1252 712222
Fax: +44 1252 733207
Home Page: www.cibavision.co.uk
Sub sid iary of: Novartis, Swit zer land (100%)
LAGAP
Full Name: Lagap Pharmaceuticals Ltd
Street Ad dress: Woolmer Way, Unit 37, Bordon,
Hamp shire GU35 9QE
Tel: +44 1420 478301
Fax: +44 1420 474427
De scrip tion: De vel oper, for mu la tor, im porter,
ex porter, dis trib u tor, pro moter, sales/detailer.
Dis trib utes, sells/de tails for other com pa nies.
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, unbranded, pre scrip tion, non-pre scrip -
tion), hos pi tal pharmaceuticals. Established 1983.
Con tacts (Pharm): Chair man: Da vid G.
Stubbins; Com mer cial Op er a tions: A. Clarke; Re -
search & De vel op ment: S. Ashworth
NOVARTIS CON SUMER HEALTH
Full Name: Novartis Con sumer Health UK Ltd
Street Ad dress: Wimblehurst Road, Horsham,
West Sus sex RH12 5AB
Tel: +44 1403 210211
Fax: +44 1403 323939
Home Page: www.novartis.co.uk
De scrip tion: De vel oper, man u fac turer, ex -
porter, pro moter, sales/detailer. Prod uct ranges
in clude: phar ma ceu ti cal prod ucts (branded, pre -
scrip tion), di etetic/nu tri tional prod ucts, herbal
prod ucts. Es tab lished 1996. 250 phar ma ceu ti cal
employees in 2006.
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 50-55 mil lion
Prod ucts (% of Sales by Lead ing 5): 60-65%
Ther a peu tic Classes (% of Sales by Lead ing
5): 65-70%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
NICOTINELL (antismoking prod uct)
OTRIVINE (na sal prep a ra tion top i cal)
SAVLON (an ti sep tic/dis in fec tant)
VOLTAROL P (antirheumatic top i cal;
antirheumatic non-steroidal)
EURAX (antipruritic)
Ther a peu tic Range:
CNS drugs other 29%
na sal prep a ra tions 11%
anti rheu ma tics top i cal 11%
cough and cold prep a ra tions 10%
an ti sep tics and dis in fec tants 8%
Lead ing Dose Forms:
liq uids 27%
med i cal dress ings 27%
creams 17%
spe cial solid forms 11%
gels/sols 10%
NOVARTIS PHARMACEUTICALS
Full Name: Novartis Pharmaceuticals UK Lim ited
Street Ad dress: Frimley Busi ness Park,
Camberley, Sur rey GU16 7SR
Tel: +44 1276 692255
Fax: +44 1276 692508
Home Page: www.novartis.co.uk
De scrip tion: Re searcher, de vel oper, man u fac -
turer, for mu la tor, packager/as sem bler, im porter,
© 2009 IMS Health In cor po rated or its af fil i ates Page 217